Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

President, CEO

Chief Medical Officer

VP, Business Development

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company is developing GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, it is also developing GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-MM02 treatment for malaria; GEO-EM01 for the treatment of fever viruses, such as Ebola, Sudan, and Marburg; GEO-LM01 for the treatment of Lassa fever. GeoVax Labs, Inc. has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; U.S. Department of Defense; Emory University; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is headquartered in Smyrna, Georgia.

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and sol...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-02-22	Premium	bought	Premium	Premium	Premium	President, CEO
2024-02-21	Premium	bought	Premium	Premium	Premium	President, CEO
2024-02-07	Premium	bought	Premium	Premium	Premium	CFO
2023-12-22	Premium	bought	Premium	Premium	Premium	Chief Medical Officer
2023-09-25	Premium	bought	Premium	Premium	Premium	Chief Medical Officer
2023-08-25	Premium	bought	Premium	Premium	Premium	President, CEO
2023-08-18	Premium	bought	Premium	Premium	Premium	CFO
2023-04-24	Premium	bought	Premium	Premium	Premium	President, CEO
2023-04-20	Premium	bought	Premium	Premium	Premium	CFO
2022-09-21	Premium	bought	Premium	Premium	Premium	-
2022-07-01	Premium	bought	Premium	Premium	Premium	VP, Business Development
2022-06-27	Premium	bought	Premium	Premium	Premium	Chief Medical Officer
2022-06-21	Premium	bought	Premium	Premium	Premium	-
2022-05-05	Premium	bought	Premium	Premium	Premium	Chief Medical Officer
2022-05-04	Premium	bought	Premium	Premium	Premium	Chief Medical Officer
2020-09-29	Premium	bought	Premium	Premium	Premium	-
2020-09-29	Premium	bought	Premium	Premium	Premium	-
2020-09-29	Premium	bought	Premium	Premium	Premium	CFO
2020-09-29	Premium	bought	Premium	Premium	Premium	-
2020-09-29	Premium	bought	Premium	Premium	Premium	President, CEO
2020-09-29	Premium	bought	Premium	Premium	Premium	-

GOVX - GeoVax Labs, Inc. Stock Price, Fair Value and News

Latest Insider Trading transactions for GOVX